BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pircher A, Medinger M, Drevs J. Liver cancer: Targeted future options. World J Hepatol 2011; 3(2): 38-44 [PMID: 21423913 DOI: 10.4254/wjh.v3.i2.38]
URL: https://www.wjgnet.com/1948-5182/full/v3/i2/38.htm
Number Citing Articles
1
V. Chatzakos, A.K. Rundlöf, D. Ahmed, P.J. de Verdier, J. Flygare. Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with seleniteBiochemical Pharmacology 2012; 84(5): 712 doi: 10.1016/j.bcp.2012.06.009
2
Saad Shaaban, Amr Negm, Abeer M. Ashmawy, Dalia M. Ahmed, Ludger A. Wessjohann. Combinatorial synthesis, in silico , molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinomaEuropean Journal of Medicinal Chemistry 2016; 122: 55 doi: 10.1016/j.ejmech.2016.06.005
3
Tao Song, Yu-Guang Shen, Na-Na Jiao, Xin-Hui Li, Hong-Tao Hu, Jin-Rong Qu, Xue-Jun Chen, Wen Feng, Xun Zhang, Hai-Liang Li. Esophageal Squamous Cell Carcinoma: Assessing Tumor Angiogenesis Using Multi-Slice CT Perfusion ImagingDigestive Diseases and Sciences 2012; 57(8): 2195 doi: 10.1007/s10620-012-2149-9
4
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
5
LONG ZHANG, XIAOHOU WU, CHUNLI LUO, XIONG CHEN, LIN YANG, JIA TAO, JUNHUI SHI. The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion moleculeMolecular Medicine Reports 2013; 8(1): 272 doi: 10.3892/mmr.2013.1458
6
Annemarie Losert, Daniela Lötsch, Andreas Lackner, Herwig Koppensteiner, Barbara Peter-Vörösmarty, Elisabeth Steiner, Klaus Holzmann, Thomas Grunt, Katharina Schmid, Brigitte Marian, Bettina Grasl-Kraupp, Rolf Schulte-Hermann, Georg Krupitza, Walter Berger, Michael Grusch. The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cellsCancer Letters 2012; 319(2): 164 doi: 10.1016/j.canlet.2012.01.002
7
Xiaojing Gong, Na Guo, Lingqin Wan, Xifeng Jia, Yishan Wang. The Hematopoietic and Immunomodulatory Effect of rhIL-12 for Liver CancerInternational Journal of Medical Physics, Clinical Engineering and Radiation Oncology 2016; 5(01): 33 doi: 10.4236/ijmpcero.2016.51004
8
A. Fassina. ‘The map is not the territory’: FNA the map and liver the territoryCytopathology 2011; 22(5): 285 doi: 10.1111/j.1365-2303.2011.00928.x
9
Anupam Bishayee, Roslin J. Thoppil, Animesh Mandal, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Erzsébet Háznagy-Radnai, Judit Hohmann, Deepak Bhatia. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory responseMolecular Carcinogenesis 2013; 52(4): 304 doi: 10.1002/mc.21860
10
Wenwen Xu, Jim Jun-hui Huang, Peter Chi Keung Cheung, Joseph Alan Bauer. Extract of Pleurotus pulmonarius Suppresses Liver Cancer Development and Progression through Inhibition of VEGF-Induced PI3K/AKT Signaling PathwayPLoS ONE 2012; 7(3): e34406 doi: 10.1371/journal.pone.0034406
11
Tingting Li, Xiaona Zhang, Shanshan Xu, Hongjie Cheng, Hong Zhang. Effectiveness and safety of adjunctive traditional Chinese medicine therapy for primary liver cancer patientsMedicine 2020; 99(31): e21281 doi: 10.1097/MD.0000000000021281
12
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
13
James E. Squires, George V. Mazariegos. Pediatric Liver Transplantation2021; : 30 doi: 10.1016/B978-0-323-63671-1.00005-7
14
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu, Hsiu-Chin Huang, Min-Chuan Huang. Mucin Glycosylating Enzyme GALNT2 Regulates the Malignant Character of Hepatocellular Carcinoma by Modifying the EGF ReceptorCancer Research 2011; 71(23): 7270 doi: 10.1158/0008-5472.CAN-11-1161
15
Shuohui Yang, Jiang Lin, Fang Lu, Zhihong Han, Caixia Fu, Hongchen Gu. Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular CarcinomaContrast Media & Molecular Imaging 2017; 2017: 1 doi: 10.1155/2017/9265098
16
Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapyCell Biology International 2021;  doi: 10.1002/cbin.11670
17
Yueh-Hsiang Liao, Cheng-Chieh Lin, Hsueh-Chou Lai, Jen-Huai Chiang, Jaung-Geng Lin, Tsai-Chung Li. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patientsLiver International 2015; 35(12): 2595 doi: 10.1111/liv.12847
18
Bernhard Kerbl, Philip Voglreiter, Rostislav Khlebnikov, Dieter Schmalstieg, Daniel Seider, Michael Moche, Philipp Stiegler, Rupert H. Portugaller, Bernhard Kainz. Clinical Image-Based Procedures. From Planning to InterventionLecture Notes in Computer Science 2013; 7761: 9 doi: 10.1007/978-3-642-38079-2_2
19
Zongguo Yang, Xian Liao, Yunfei Lu, Qingnian Xu, Bozong Tang, Xiaorong Chen, Yongchun Yu. Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/3428253
20
L. V. Klotz, M. E. Eichhorn, B. Schwarz, H. Seeliger, M. K. Angele, K.-W. Jauch, Christiane J. Bruns. Targeting the vasculature of visceral tumors: novel insights and treatment perspectivesLangenbeck's Archives of Surgery 2012; 397(4): 569 doi: 10.1007/s00423-012-0946-4
21
Shuo-hui Yang, Jiang Lin, Fang Lu, Zhi-hong Han, Cai-xia Fu, Peng Lv, Hao Liu, Dong-mei Gao. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft modelJournal of Magnetic Resonance Imaging 2017; 45(1): 270 doi: 10.1002/jmri.25344
22
Maciej Murawski, Víola B. Weeda, Rudolf Maibach, Bruce Morland, Derek J. Roebuck, Arthur Zimmerman, Michela Casanova, Giorgio Perilongo, Veronique Laithier, Rejin Kebudi, Marcelo J. Scopinaro, Albert Shun, Benedicte Brichard, Beatriz de Camargo, Margaret Childs, Daniel C. Aronson, Piotr Czauderna. Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 StudiesJournal of Clinical Oncology 2016; 34(10): 1050 doi: 10.1200/JCO.2014.60.2250
23
Nikolaus Jilg, Raymond T. Chung. Adding to the toolbox: Receptor tyrosine kinases as potential targets in the treatment of hepatitis CJournal of Hepatology 2012; 56(1): 282 doi: 10.1016/j.jhep.2011.06.020
24
Gaiping Wang, Cunshuan Xu, Jia Zhi, Yunpeng Hao, Lianxing Zhang, Cuifang Chang. Gene expression profiles reveal significant differences between rat liver cancer and liver regenerationGene 2012; 504(1): 41 doi: 10.1016/j.gene.2012.04.086
25
Andreea Cioca, Anca Cimpean, Raluca Ceausu, Ana-Maria Fit, Teodor Zaharie, Nadim Al-Hajjar, Vlad Puia, Marius Raica. Crosstalk between EGFR and p53 in Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2014; 15(19): 8069 doi: 10.7314/APJCP.2014.15.19.8069
26
Zhan Zheng, William Chi-Shing Cho, Ling Xu, Juyong Wang, Daniel Man-Yuen Sze. Lessons Learnt from Evidence-Based Approach of Using Chinese Herbal Medicines in Liver CancerEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/656351